Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 4 $ 113,329 $ (869) $ (34,616) $ 77,848
Balance (in shares) at Dec. 31, 2023 35,302        
Balance, Treasury Stock (in shares) at Dec. 31, 2023     712    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation   709     709
Net loss       (11,272) (11,272)
Balance at Mar. 31, 2024 $ 4 114,038 $ (869) (45,888) 67,285
Balance (in shares) at Mar. 31, 2024 35,302        
Balance, Treasury Stock (in shares) at Mar. 31, 2024     712    
Balance at Dec. 31, 2023 $ 4 113,329 $ (869) (34,616) 77,848
Balance (in shares) at Dec. 31, 2023 35,302        
Balance, Treasury Stock (in shares) at Dec. 31, 2023     712    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (19,901)
Balance at Jun. 30, 2024 $ 4 114,580 $ (613) (54,517) 59,454
Balance (in shares) at Jun. 30, 2024 35,302        
Balance, Treasury Stock (in shares) at Jun. 30, 2024     503    
Balance at Mar. 31, 2024 $ 4 114,038 $ (869) (45,888) 67,285
Balance (in shares) at Mar. 31, 2024 35,302        
Balance, Treasury Stock (in shares) at Mar. 31, 2024     712    
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Options exercised and restricted stocks vested   (198) $ 256   58
Options exercised and restricted stocks vested (in shares)     (209)    
Stock-based compensation   740     740
Net loss       (8,629) (8,629)
Balance at Jun. 30, 2024 $ 4 114,580 $ (613) (54,517) 59,454
Balance (in shares) at Jun. 30, 2024 35,302        
Balance, Treasury Stock (in shares) at Jun. 30, 2024     503    
Balance at Dec. 31, 2024 $ 4 115,781   (75,288) 40,497
Balance (in shares) at Dec. 31, 2024 35,649        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Options exercised   485     485
Options exercised (in shares) 327        
Stock-based compensation   575     575
Cancellation of performance-based shares   (792)     (792)
Net loss       (9,765) (9,765)
Balance at Mar. 31, 2025 $ 4 116,049   (85,053) 31,000
Balance (in shares) at Mar. 31, 2025 35,976        
Balance at Dec. 31, 2024 $ 4 115,781   (75,288) 40,497
Balance (in shares) at Dec. 31, 2024 35,649        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss         (20,148)
Balance at Jun. 30, 2025 $ 4 116,643   (95,436) 21,211
Balance (in shares) at Jun. 30, 2025 36,111        
Balance at Mar. 31, 2025 $ 4 116,049   (85,053) 31,000
Balance (in shares) at Mar. 31, 2025 35,976        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted stocks vested, (in shares) 135        
Stock-based compensation   594     594
Net loss       (10,383) (10,383)
Balance at Jun. 30, 2025 $ 4 $ 116,643   $ (95,436) $ 21,211
Balance (in shares) at Jun. 30, 2025 36,111